The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...

Hundreds of people in the UK have reported problems with their pancreas linked to taking weight loss and diabetes injections, prompting health officials to begin a study into side-effects. Some cases ...

MHRA says users of jabs such as Wegovy and Mounjaro reported inflamed pancreas - which can cause agonising abdominal pain - ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...

All too often celebrities will tell a white lie when asked the secret to their new figure after drastic weight loss, but Amy ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

Universal access to GLP-1 receptor agonists for eligible populations could reduce global obesity prevalence by half and save ...

US Health Secretary Kennedy says HHS to launch campaign to encourage wearable devices – Nation and World News | West Hawaii Today ...

Berger Montague, a nationally recognized securities litigation firm, is investigating potential claims on behalf of investors who purchased or otherwise acquired securities of Hims ...